- ►annals.org RS Raymond, MB Fallon, GA Abrams - Annals of internal medicine, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Background: Hepatitis C is an
important cause of chronic liver disease. It is claimed that Complete Thymic Formula, an ... Cited by 10 - Related articles - All 7 versions
[CITATION] Levamisole and interferon alfa-2b as combination therapy for chronic hepatitis C: …
- ►nih.gov [PDF] S SCHALM - Gut, 1998 - pubmedcentral.nih.gov Adding ribavirin to interferon -2b for chronic hepatitis C ... Reichard O, Norkrans G, Frydén
A, et al for the Swedish Study Group. Randomised, double-blind, placebo-controlled trial of interferon
-2b with and without ribavirin for chronic hepatitis C. Lancet 1998 Jan 10;351:83–7. Cited by 5 - Related articles - All 5 versions
A Vegnente, R Iorio, P Pensati - Acta gastro-enterologica Belgica - ncbi.nlm.nih.gov 1: Acta Gastroenterol Belg. 1998 Apr-Jun;61(2):235-6. Treatment of pediatric hepatitis
C: results and perspectives. Vegnente A, Iorio R, Pensati P. Dipartimento di Pediatria,
Universita di Napoli Frederico II, Italy. Publication Types ... Cited by 7 - Related articles
GB Gaeta, D Di Virgilio, G Russo, G … - Journal of Viral …, 1997 - interscience.wiley.com Patients with biopsy-proven chronic hepatitis C, who failed to respond to a previous course of
either recombinant (rIFN-α) or lymphoblastoid (LyIFN-α) interferon-α, were randomized to receive
either leucocyte (Le) IFN-α (patients) or a second course of the same IFN-α (controls), to ... Cited by 8 - Related articles - All 3 versions
[CITATION] cell receptor gene transfer: a potential novel therapy for hepatitis C virus infection
